Dr. Ryan Little, MD

NPI: 1679990808
Total Payments
$1,238
2024 Payments
$172.56
Companies
4
Transactions
13
Medicare Patients
1,756
Medicare Billing
$217,900

Payment Breakdown by Category

Research$903.09 (72.9%)
Food & Beverage$275.21 (22.2%)
Consulting$60.00 (4.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $903.09 6 72.9%
Food and Beverage $275.21 6 22.2%
Consulting Fee $60.00 1 4.8%

Payments by Type

Research
$903.09
6 transactions
General
$335.21
7 transactions

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $903.09 6 $0 (2023)
Stryker Corporation $245.72 4 $0 (2024)
Medtronic, Inc. $75.53 2 $0 (2024)
Janssen Biotech, Inc. $13.96 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $172.56 2 Stryker Corporation ($112.56)
2023 $918.62 7 GlaxoSmithKline, LLC. ($903.09)
2022 $147.12 4 Stryker Corporation ($133.16)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/01/2024 Medtronic, Inc. NUVENT (Device) Consulting Fee Cash or cash equivalent $60.00 General
Category: Sinus Surgery
04/05/2024 Stryker Corporation XPRESS LOPROFILE (Device) Food and Beverage In-kind items and services $112.56 General
Category: ENTELLUS
05/19/2023 Medtronic, Inc. STEALTHSTATION S8 PLATFORM (Device) Food and Beverage In-kind items and services $15.53 General
Category: Image Guided Surgery Products
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $523.42 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $177.98 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $75.71 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $62.82 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $54.17 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
03/22/2023 GlaxoSmithKline, LLC. In-kind items and services $8.99 Research
Study: A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T
06/28/2022 Stryker Corporation LATERA (Device) Food and Beverage In-kind items and services $19.84 General
Category: SPIROX
06/03/2022 Stryker Corporation N/A (Device) Food and Beverage In-kind items and services $49.93 General
Category: NEURO SPINE ENT
06/01/2022 Stryker Corporation N/A (Device) Food and Beverage In-kind items and services $63.39 General
Category: NEURO SPINE ENT
05/17/2022 Janssen Biotech, Inc. SYMTUZA (Drug) Food and Beverage In-kind items and services $13.96 General
Category: Infectious Diseases & Vaccines

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T GlaxoSmithKline, LLC. $903.09 6

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 427 457 $760,353 $46,767
2022 14 608 731 $1.3M $81,611
2021 14 585 747 $918,794 $78,114
2020 4 136 146 $42,300 $11,409
Total Patients
1,756
Total Services
2,081
Medicare Billing
$217,900
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
31231 Diagnostic exam of nasal passages using an endoscope Facility 2023 149 166 $60,950 $7,500 12.3%
31259 Removal of tissue from sphenoid sinus using an endoscope Facility 2023 14 14 $212,125 $7,473 3.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 78 86 $13,744 $5,845 42.5%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 61 61 $16,987 $5,622 33.1%
31237 Biopsy or removal of nasal polyp or tissue using an endoscope Facility 2023 28 33 $43,848 $5,116 11.7%
31267 Removal of nasal sinus tissue using an endoscope Facility 2023 22 22 $165,480 $4,698 2.8%
31276 Exploration of nasal sinus using an endoscope Facility 2023 13 13 $142,287 $4,611 3.2%
61782 Computer-assisted procedure outside membrane covering brain Facility 2023 22 22 $77,110 $3,011 3.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 14 14 $5,265 $1,657 31.5%
30930 Therapeutic fracture of nasal passages Facility 2023 26 26 $22,557 $1,233 5.5%
31259 Removal of tissue from sphenoid sinus using an endoscope Facility 2022 26 26 $363,722 $13,162 3.6%
31231 Diagnostic exam of nasal passages using an endoscope Facility 2022 179 253 $89,837 $12,171 13.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 99 138 $20,068 $10,414 51.9%
31276 Exploration of nasal sinus using an endoscope Facility 2022 23 23 $223,509 $7,457 3.3%
31267 Removal of nasal sinus tissue using an endoscope Facility 2022 36 36 $261,842 $7,418 2.8%
30520 Reshaping of nasal cartilage Facility 2022 18 18 $162,288 $6,898 4.3%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 58 58 $15,073 $5,993 39.8%
31237 Biopsy or removal of nasal polyp or tissue using an endoscope Facility 2022 31 38 $39,274 $5,902 15.0%
61782 Computer-assisted procedure outside membrane covering brain Facility 2022 35 35 $111,615 $4,738 4.2%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 31 31 $5,633 $1,944 34.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 12 12 $4,004 $1,773 44.3%
30930 Therapeutic fracture of nasal passages Facility 2022 34 34 $26,486 $1,691 6.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 11 11 $2,318 $1,290 55.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 15 18 $1,780 $760.45 42.7%
31231 Diagnostic examination of nasal passages using an endoscope Facility 2021 167 259 $89,469 $12,967 14.5%

About Dr. Ryan Little, MD

Dr. Ryan Little, MD is a Otolaryngology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1679990808.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Little, MD has received a total of $1,238 in payments from pharmaceutical and medical device companies, with $172.56 received in 2024. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "" ($903.09).

As a Medicare-enrolled provider, Little has provided services to 1,756 Medicare beneficiaries, totaling 2,081 services with total Medicare billing of $217,900. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Otolaryngology
  • Other Specialties Otolaryngology
  • Location Lebanon, NH
  • Active Since 03/26/2014
  • Last Updated 07/21/2020
  • Taxonomy Code 207Y00000X
  • Entity Type Individual
  • NPI Number 1679990808

Products in Payments

  • N/A (Device) $113.32
  • XPRESS LOPROFILE (Device) $112.56
  • NUVENT (Device) $60.00
  • LATERA (Device) $19.84
  • STEALTHSTATION S8 PLATFORM (Device) $15.53
  • SYMTUZA (Drug) $13.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Otolaryngology Doctors in Lebanon